Viewing nowCombinationDucapin Tablet 60/2.5 mg
Fimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Aprogen Biosciences Co., Ltd.

MFDS item code 202300113 · Approved 2023.01.06
Treatment of essential hypertension not controlled with fimasartan monotherapy
This medication is used in patients with essential hypertension whose blood pressure is not adequately controlled by Pimasartan monotherapy.
Adults The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. Before starting this medicine, it is recommended that the dose be adjusted using fimasartan. However, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/2.5 milligrams: For patients whose blood pressure is not adequately controlled with fimasartan 30 milligrams as monotherapy. ㆍ 60/2.5 milligrams: For patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams as monotherapy. ㆍ 60/5 milligrams: For patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams as monotherapy or this medicine 60/2.5 milligrams. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Elderly patients No initial dose adjustment is required for elderly patients aged 70 years or younger. Patients with renal impairment No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min). However, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 milligrams in this medicine. Patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment. This medicine should not be administered to patients with moderate to severe hepatic impairment.
The safety and efficacy of this medicine in pediatric and adolescent patients aged 18 years or younger have not been established.
This medication may cause serious harm or death to the fetus and newborn, especially during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Patients who have allergies to the ingredients of this medication, who are undergoing kidney dialysis, who have moderate to severe liver impairment, or who have biliary obstruction should not take this medication. Patients with low blood volume, low salt levels, compromised kidney function, renal artery hypertension, cardiac valve disease, primary aldosteronism, severe hypotension, and the elderly should take special care when using this medication. This medication may rarely cause side effects such as dizziness, headache, edema, urinary disorders, insomnia, and flushing, so if any of these symptoms occur, consult a healthcare professional. Symptoms of hypotension or electrolyte imbalance may occur, so particularly patients taking high doses of diuretics should closely monitor their blood pressure and condition when starting this medication or increasing the dosage. Patients with heart failure or poor kidney function should undergo regular blood tests due to the risk of elevated serum potassium levels. This medication may interact with other antihypertensives, certain diuretics, lithium, and non-steroidal anti-inflammatory drugs, so other medications being taken should be disclosed. It is advisable for pregnant and breastfeeding women not to take this medication and to consult with healthcare professionals if necessary. Safety in children and adolescents under 18 years has not been established, so use is not recommended. In case of overdose, symptoms such as hypotension or abnormal heart rhythms may occur, and immediate medical treatment should be sought. This medication should be kept out of reach of children and it is advised not to transfer it to other containers for safety.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a container that blocks light and air, preferably at a temperature between 1 and 30 degrees Celsius. Storing it this way will help maintain the medication's effectiveness over time.
Yellow, round-cornered, film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Aprogen Biosciences Co., Ltd.
CombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 7.48mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
NBK Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Ajou Pharmaceuticals Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Kips Biopharma Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Bionex Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.